scholarly article | Q13442814 |
P50 | author | Catrin Tudur Smith | Q87140163 |
P2093 | author name string | Anthony G Marson | |
Lisa Williams | |||
Sally Reynolds | |||
Sarah J Nevitt | |||
Becky Davie | |||
P2860 | cites work | Empirical study of data sharing by authors publishing in PLoS journals | Q21142746 |
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review | Q24185852 | ||
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review | Q24186327 | ||
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review | Q24187872 | ||
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures | Q24201696 | ||
Oxcarbazepine versus phenytoin monotherapy for epilepsy | Q24202768 | ||
Lamotrigine versus carbamazepine monotherapy for epilepsy | Q24244885 | ||
Oxcarbazepine versus phenytoin monotherapy for epilepsy | Q24246413 | ||
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures | Q24248718 | ||
Carbamazepine versus phenobarbitone monotherapy for epilepsy | Q24250193 | ||
Access to Patient-Level Data from GlaxoSmithKline Clinical Trials | Q24289276 | ||
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial | Q24676550 | ||
Participant-Level Data and the New Frontier in Trial Transparency | Q24718196 | ||
How should individual participant data (IPD) from publicly funded clinical trials be shared? | Q28604049 | ||
Opening clinical trial data: are the voluntary data-sharing portals enough? | Q28607541 | ||
How individual participant data meta-analyses have influenced trial design, conduct, and analysis | Q28607751 | ||
Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey | Q28654786 | ||
A failed attempt to conduct an individual patient data meta-analysis | Q28655731 | ||
Sharing of clinical trial data among trialists: a cross sectional survey | Q28710576 | ||
The nuts and bolts of PROSPERO: an international prospective register of systematic reviews | Q28736175 | ||
Whose data set is it anyway? Sharing raw data from randomized trials | Q28768500 | ||
Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use | Q30000075 | ||
Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials | Q30610862 | ||
A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis | Q30669346 | ||
To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data | Q30676636 | ||
Why did it take 19 months to retrieve clinical trial data from a non-profit organisation? | Q30706142 | ||
Distribution and epidemiological characteristics of published individual patient data meta-analyses | Q30832212 | ||
Data sharing, year 1--access to data from industry-sponsored clinical trials | Q30860404 | ||
Carbamazepine versus valproate monotherapy for epilepsy | Q30887426 | ||
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study | Q30906124 | ||
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement | Q30940208 | ||
A decade of individual participant data meta-analyses: A review of current practice | Q30975392 | ||
Get real in individual participant data (IPD) meta-analysis: a review of the methodology | Q30988193 | ||
Are manufacturers sharing data as promised? | Q30997496 | ||
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. | Q31016826 | ||
Carbamazepine versus phenytoin monotherapy for epilepsy | Q31083753 | ||
Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods | Q31108600 | ||
Individual participant data meta-analyses compared with meta-analyses based on aggregate data | Q31126782 | ||
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. | Q31142199 | ||
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. | Q31147165 | ||
Meta-analysis of individual participant data: rationale, conduct, and reporting | Q33530020 | ||
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey | Q34116497 | ||
Meta-analysis of the literature or of individual patient data: is there a difference? | Q34334544 | ||
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures | Q34424616 | ||
Considerations on Designing Clinical Trials to Evaluate the Place of New Antiepileptic Drugs in the Treatment of Newly Diagnosed and Chronic Patients with Epilepsy | Q74791650 | ||
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the condu | Q81456691 | ||
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial | Q34611908 | ||
Multiple treatment comparisons in epilepsy monotherapy trials | Q34710058 | ||
The levels of evidence and their role in evidence-based medicine | Q35072317 | ||
Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group | Q36790212 | ||
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews | Q37692721 | ||
Empirical assessment of effect of publication bias on meta-analyses. | Q38630464 | ||
Sharing Clinical Trial Data--A Proposal from the International Committee of Medical Journal Editors | Q42672446 | ||
Searching for information from unreported trials--amnesty for the past and prospective meta-analyses for the future. | Q52901680 | ||
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data | Q57689494 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | meta-analysis | Q815382 |
biomedical investigative technique | Q66648976 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | j1390 | |
P577 | publication date | 2017-04-05 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
systematic review | Q1504425 | ||
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review | |
P478 | volume | 357 |
Q64904319 | Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data. |
Q64091450 | Evaluation of repositories for sharing individual-participant data from clinical studies |
Q47734438 | Meta-analysis of randomized clinical trials in the era of individual patient data sharing |
Q58569369 | Online Family Problem-solving Treatment for Pediatric Traumatic Brain Injury |
Q55345267 | Systematic reviews and cancer research: a suggested stepwise approach. |
Q91990116 | Trial Corresponding Author Country, Year, and Journal Impact Factor Associated with Data Contribution to IPDMAs |
Search more.